James Tataw

ORCID: 0000-0003-0248-7396
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurological and metabolic disorders
  • Renal function and acid-base balance
  • Organ Donation and Transplantation
  • Acute Kidney Injury Research
  • Chronic Kidney Disease and Diabetes
  • Aortic Thrombus and Embolism
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Pharmacological Effects and Toxicity Studies
  • Clinical Reasoning and Diagnostic Skills
  • Healthcare Systems and Practices
  • Acute Ischemic Stroke Management
  • Muscle and Compartmental Disorders
  • Hormonal Regulation and Hypertension
  • Dialysis and Renal Disease Management
  • Vitamin C and Antioxidants Research
  • Electrolyte and hormonal disorders
  • Pericarditis and Cardiac Tamponade
  • Blood Pressure and Hypertension Studies
  • Adrenal Hormones and Disorders
  • Trauma, Hemostasis, Coagulopathy, Resuscitation

Hôpital du Jura Bernois
2019-2024

Hôpital Beau-Séjour
2022

University of Geneva
2015

HES-SO Genève
2012

Abstract Introduction A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients undergoing continuous renal replacement therapy (CRRT). regional citrate-based (RCA) does not induce a prolongs the lifespan, but metabolic side-effects have been associated with this therapy. We conducted randomized controlled trial requiring CRRT determine whether RCA using balanced predilution fluid more effective than heparin terms of delivered dose safety profile....

10.1186/s13054-015-0822-z article EN cc-by Critical Care 2015-02-26

Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a recent single regimen for the treatment of Human Immunodeficiency Virus (HIV). However, because its complexity, it difficult to predict drug interactions, especially when associated with HMG-CoA reductase inhibitors and/or in setting other comorbidities. We discuss mechanisms these potential interactions as cause rhabdomyolysis and acute kidney injury context prior current medication therapy possible underlying liver...

10.1186/s12882-019-1257-6 article EN cc-by BMC Nephrology 2019-02-26

A 90-year-old patient with chronic kidney disease (stage G4) was diagnosed pneumonia and congestive heart failure. Despite treatment levofloxacin furosemide, his condition deteriorated. CT scan of the chest revealed pericardial effusion, leading to suspicion uremic pericarditis. Daily hemodialysis started, resulting in significant clinical biological improvement. Uremic pericarditis due accumulation toxins effusion is common end-stage renal disease. Diagnosis guided by paraclinical findings...

10.53738/revmed.2024.20.894.2081 article EN Revue Médicale Suisse 2024-01-01

A 44-year-old patient was admitted to the emergency department for uncontrollable vomiting, weakness, and headache. His medical history included regular episodes of migraines traumatic brain injury at age 11. Upon admission, confused with stable vital signs. The epigastrium slightly sensitive. Additional examinations (ECG laboratory analysis) were unremarkable, clinicians thought it gastroenteritis. detailed interview revealed that had been taking daily hydrocortisone treat...

10.53738/revmed.2023.19.814.338 article EN Revue Médicale Suisse 2023-01-01

Chronic kidney disease (CKD) has a high prevalence in Cameroon and will become an important public health problem. Its management must be comprehensive, starting with CKD prevention to the implementation of renal replacement therapies best suited needs patients resources available Cameroon. Practical interventions involving nephrology departments both Africa Europe can contribute improved Africa. The current collaboration between Geneva University Hospitals Yaoundé teaching hospitals is...

10.53738/revmed.2023.19.816.417 article FR Revue Médicale Suisse 2023-01-01
Coming Soon ...